People taking other medications Both tirzepatide and semaglutide slow gastric emptying, which can affect absorption of oral medications
The label warns separately about acute kidney injury due to volume depletion and instructs monitoring of renal function in patients reporting adverse reactions that could lead to it
Current evidence comes mostly from trials funded by the drug makers, with multiple sources of bias
Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG , Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ
Figure 1 provides an illustrative overview of these disorders
Ozempic (semaglutide) received FDA approval for treating Type 2 diabetes